Boryung (KRX:003850) will establish a new split company named Boryung Pharma Solution, according to a Tuesday filing with the Korea Exchange.
The new company will cater to prescription drug sales and marketing.
Boryung will survive as a listed company while Boryung Pharma Solution will be unlisted.
The split will be effective on Jan. 4, 2027.
Shares of the pharmaceutical company fell nearly 8% in recent trade.